Your search returned 7 results.

Results
	1.	Targeting the cell cycle in breast cancer: towards the next phase. [electronic resource] by Thu, K L Soria-Bretones, I Mak, T W Cescon, D W Producer: 20190920 In: Cell cycle (Georgetown, Tex.) vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer. [electronic resource] by Seruga, B Hertz, P C Wang, L Booth, C M Cescon, D W Krzyzanowska, M Tannock, I F Producer: 20100930 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	p53 Arg72Pro, MDM2 T309G and CCND1 G870A polymorphisms are not associated with susceptibility to esophageal adenocarcinoma. [electronic resource] by Liu, G Cescon, D W Zhai, R Zhou, W Kulke, M H Ma, C Xu, W Su, L Asomaning, K Heist, R S Wain, J C Lynch, T J Christiani, D C Producer: 20100914 In: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus vol. 23 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer. [electronic resource] by Thu, K L Silvester, J Elliott, M J Ba-Alawi, W Duncan, M H Elia, A C Mer, A S Smirnov, P Safikhani, Z Haibe-Kains, B Mak, T W Cescon, D W Producer: 20180903 In: Proceedings of the National Academy of Sciences of the United States of America vol. 115 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study. [electronic resource] by Adams, S Loi, S Toppmeyer, D Cescon, D W De Laurentiis, M Nanda, R Winer, E P Mukai, H Tamura, K Armstrong, A Liu, M C Iwata, H Ryvo, L Wimberger, P Rugo, H S Tan, A R Jia, L Ding, Y Karantza, V Schmid, P Producer: 20200324 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Pembrolizumab monotherapy for previously treated metastatic triple-negative breast cancer: cohort A of the phase II KEYNOTE-086 study. [electronic resource] by Adams, S Schmid, P Rugo, H S Winer, E P Loirat, D Awada, A Cescon, D W Iwata, H Campone, M Nanda, R Hui, R Curigliano, G Toppmeyer, D O'Shaughnessy, J Loi, S Paluch-Shimon, S Tan, A R Card, D Zhao, J Karantza, V Cortés, J Producer: 20200324 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 30 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Idh1 protects murine hepatocytes from endotoxin-induced oxidative stress by regulating the intracellular NADP(+)/NADPH ratio. [electronic resource] by Itsumi, M Inoue, S Elia, A J Murakami, K Sasaki, M Lind, E F Brenner, D Harris, I S Chio, I I C Afzal, S Cairns, R A Cescon, D W Elford, A R Ye, J Lang, P A Li, W Y Wakeham, A Duncan, G S Haight, J You-Ten, A Snow, B Yamamoto, K Ohashi, P S Mak, T W Producer: 20160509 In: Cell death and differentiation vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)